Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 InhibitorsOscar Hou In Chou, Jiandong Zhou, Helen Huang et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 24